Fundies.
English

Segment disclosures

Company overview

Clever Leaves Holdings Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

5 dimension combinations 71 retained observations 17 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Cannabinoid

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clvr:CannabinoidMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-316558000 USD20240401Open filing evidence
2023-07-01 – 2023-09-301442000 USD20231109Open filing evidence
2023-01-01 – 2023-09-304537000 USD20231109Open filing evidence
2022-01-01 – 2022-12-314729000 RestatedUSD20240401Open filing evidence
2022-07-01 – 2022-09-30613000 USD20231109Open filing evidence
2022-01-01 – 2022-09-303166000 USD20231109Open filing evidence
2022-01-01 – 2022-03-311994000 USD20220512Open filing evidence
2021-01-01 – 2021-12-313242000 USD20230330Open filing evidence
2021-04-01 – 2021-06-30579000 USD20210816Open filing evidence
2021-01-01 – 2021-06-301256000 USD20210816Open filing evidence
2021-01-01 – 2021-03-31677000 USD20220512Open filing evidence
2020-01-01 – 2020-12-312511000 USD20210816Open filing evidence
2020-04-01 – 2020-06-30153000 USD20210816Open filing evidence
2020-01-01 – 2020-06-30395000 USD20210816Open filing evidence
2019-01-01 – 2019-12-31133000 USD20210816Open filing evidence

Operating Segments · Non Cannabinoid

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clvr:NonCannabinoidMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3110859000 USD20240401Open filing evidence
2023-07-01 – 2023-09-302378000 USD20231109Open filing evidence
2023-01-01 – 2023-09-308242000 USD20231109Open filing evidence
2022-01-01 – 2022-12-3111681000 USD20240401Open filing evidence
2022-07-01 – 2022-09-302254000 RestatedUSD20231109Open filing evidence
2022-01-01 – 2022-09-308842000 RestatedUSD20231109Open filing evidence
2022-04-01 – 2022-06-303358000 USD20220811Open filing evidence
2022-01-01 – 2022-06-306591000 USD20220811Open filing evidence
2022-01-01 – 2022-03-313230000 USD20220512Open filing evidence
2021-01-01 – 2021-12-3112132000 USD20230330Open filing evidence
2021-07-01 – 2021-09-303156000 RestatedUSD20221109Open filing evidence
2021-01-01 – 2021-09-309049000 RestatedUSD20221109Open filing evidence
2021-04-01 – 2021-06-303093000 USD20220811Open filing evidence
2021-01-01 – 2021-06-305893000 USD20220811Open filing evidence
2021-01-01 – 2021-03-312800000 USD20220512Open filing evidence
2020-01-01 – 2020-12-319606000 USD20220324Open filing evidence
2020-07-01 – 2020-09-302781000 USD20211110Open filing evidence
2020-01-01 – 2020-09-307239000 USD20211110Open filing evidence
2020-04-01 – 2020-06-301786000 USD20210816Open filing evidence
2020-01-01 – 2020-06-304458000 USD20210816Open filing evidence
2019-01-01 – 2019-12-317701000 USD20210816Open filing evidence

US · Operating Segments · Non Cannabinoid

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clvr:NonCannabinoidMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-09-308700000 USD20221109Open filing evidence
2022-01-01 – 2022-06-306500000 USD20220811Open filing evidence
2021-01-01 – 2021-09-308700000 USD20221109Open filing evidence
2021-01-01 – 2021-06-306500000 USD20220811Open filing evidence

Cannabinoid · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=clvr:CannabinoidMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-301873000 USD20230814Open filing evidence
2023-01-01 – 2023-06-303095000 USD20230814Open filing evidence
2023-01-01 – 2023-03-311222000 USD20230511Open filing evidence
2022-07-01 – 2022-09-30979000 USD20221109Open filing evidence
2022-01-01 – 2022-09-304269000 USD20221109Open filing evidence
2022-04-01 – 2022-06-30745000 RestatedUSD20230814Open filing evidence
2022-01-01 – 2022-06-302553000 RestatedUSD20230814Open filing evidence
2022-01-01 – 2022-03-311811000 USD20230511Open filing evidence
2021-01-01 – 2021-12-313242000 USD20220324Open filing evidence
2021-07-01 – 2021-09-30875000 RestatedUSD20221109Open filing evidence
2021-01-01 – 2021-09-302131000 RestatedUSD20221109Open filing evidence
2021-04-01 – 2021-06-30579000 USD20220811Open filing evidence
2021-01-01 – 2021-06-301256000 USD20220811Open filing evidence
2021-01-01 – 2021-03-31677000 USD20210517Open filing evidence
2020-01-01 – 2020-12-312511000 USD20220324Open filing evidence
2020-07-01 – 2020-09-301136000 USD20211110Open filing evidence
2020-01-01 – 2020-09-301531000 USD20211110Open filing evidence
2020-04-01 – 2020-06-30153000 USD20210812Open filing evidence
2020-01-01 – 2020-06-30395000 USD20210812Open filing evidence
2020-01-01 – 2020-03-31242000 USD20210517Open filing evidence
2019-01-01 – 2019-12-31133000 USD20210514Open filing evidence

Non Cannabinoid · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=clvr:NonCannabinoidMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-303108000 USD20230814Open filing evidence
2023-01-01 – 2023-06-305864000 USD20230814Open filing evidence
2023-01-01 – 2023-03-312756000 USD20230511Open filing evidence
2022-04-01 – 2022-06-303355000 USD20230814Open filing evidence
2022-01-01 – 2022-06-306588000 USD20230814Open filing evidence
2022-01-01 – 2022-03-313230000 USD20230511Open filing evidence
2021-01-01 – 2021-03-312800000 USD20210517Open filing evidence
2020-01-01 – 2020-12-319606000 USD20210514Open filing evidence
2020-01-01 – 2020-03-312672000 USD20210517Open filing evidence
2019-01-01 – 2019-12-317701000 USD20210514Open filing evidence